Works matching AU Giorgino, Francesco

Results: 192
    1
    2

    Role of Glucose-Lowering Medications in Erectile Dysfunction.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2501, doi. 10.3390/jcm10112501
    By:
    • Cignarelli, Angelo;
    • Genchi, Valentina Annamaria;
    • D'Oria, Rossella;
    • Giordano, Fiorella;
    • Caruso, Irene;
    • Perrini, Sebastio;
    • Natalicchio, Annalisa;
    • Laviola, Luigi;
    • Giorgino, Francesco
    Publication type:
    Article
    3
    4

    Practical strategies to manage obesity in type 2 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2029, doi. 10.1111/dom.15556
    By:
    • Rodbard, Helena W.;
    • Barnard‐Kelly, Katharine;
    • Pfeiffer, Andreas F. H.;
    • Mauersberger, Carina;
    • Schnell, Oliver;
    • Giorgino, Francesco
    Publication type:
    Article
    5

    The real‐world observational prospective study of health outcomes with dulaglutide and liraglutide in patients with type 2 diabetes (TROPHIES): Final, 24‐month analysis of time to first significant treatment change, treatment persistence and clinical outcomes

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3465, doi. 10.1111/dom.15244
    By:
    • Giorgino, Francesco;
    • Guerci, Bruno;
    • Füchtenbusch, Martin;
    • Lebrec, Jérémie;
    • Boye, Kristina;
    • Orsini Federici, Marco;
    • Heitmann, Elke;
    • Dib, Anne;
    • Yu, Maria;
    • Sapin, Hélène;
    • García‐Pérez, Luis‐Emilio
    Publication type:
    Article
    6

    The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Final patient‐reported outcomes at 24 months.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3453, doi. 10.1111/dom.15145
    By:
    • Boye, Kristina S.;
    • Lebrec, Jérémie;
    • Dib, Anne;
    • Heitmann, Elke;
    • Federici, Marco Orsini;
    • Yu, Maria;
    • Sapin, Hélène;
    • Barrett, Annabel;
    • Guerci, Bruno;
    • Giorgino, Francesco;
    • Füchtenbusch, Martin;
    • García‐Pérez, Luis‐Emilio
    Publication type:
    Article
    7
    8
    9

    New insights into the treatment of obesity.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2058, doi. 10.1111/dom.15077
    By:
    • Blüher, Matthias;
    • Aras, Mohini;
    • Aronne, Louis J.;
    • Batterham, Rachel L.;
    • Giorgino, Francesco;
    • Ji, Linong;
    • Pietiläinen, Kirsi H.;
    • Schnell, Oliver;
    • Tonchevska, Elena;
    • Wilding, John P.H.
    Publication type:
    Article
    10
    11
    12
    13
    14

    T he R eal‐World O bservational P rospective Study of H ealth Outcomes with Dulaglut i de and Liraglutide in Patients with Typ e 2 Diabete s (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2373, doi. 10.1111/dom.14823
    By:
    • Guerci, Bruno;
    • Giorgino, Francesco;
    • Sapin, Hélène;
    • Boye, Kristina;
    • Lebrec, Jérémie;
    • Federici, Marco Orsini;
    • Heitmann, Elke;
    • Dib, Anne;
    • Füchtenbusch, Martin;
    • García‐Pérez, Luis‐Emilio
    Publication type:
    Article
    15
    16

    Ladarixin, an inhibitor of the interleukin‐8 receptors CXCR1 and CXCR2, in new‐onset type 1 diabetes: A multicentre, randomized, double‐blind, placebo‐controlled trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1840, doi. 10.1111/dom.14770
    By:
    • Piemonti, Lorenzo;
    • Keymeulen, Bart;
    • Gillard, Pieter;
    • Linn, Thomas;
    • Bosi, Emanuele;
    • Rose, Ludger;
    • Pozzilli, Paolo;
    • Giorgino, Francesco;
    • Cossu, Efisio;
    • Daffonchio, Luisa;
    • Goisis, Giovanni;
    • Ruffini, Pier Adelchi;
    • Maurizi, Anna Rita;
    • Mantelli, Flavio;
    • Allegretti, Marcello
    Publication type:
    Article
    17
    18

    Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon‐like peptide‐1 receptor agonists or sodium‐glucose cotransporter‐2 inhibitors: A real‐world study in two Italian cohorts.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1484, doi. 10.1111/dom.14361
    By:
    • Baviera, Marta;
    • Genovese, Stefano;
    • Lepore, Vito;
    • Colacioppo, Pierluca;
    • Robusto, Fabio;
    • Tettamanti, Mauro;
    • D'Ettorre, Antonio;
    • Avanzini, Fausto;
    • Fortino, Ida;
    • Nicolucci, Antonio;
    • Roncaglioni, Maria C.;
    • Giorgino, Francesco
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Cover Image, Volume 21, Issue 12.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. i, doi. 10.1111/dom.13903
    By:
    • Giorgino, Francesco;
    • Shaunik, Alka;
    • Liu, Minzhi;
    • Saremi, Aramesh
    Publication type:
    Article
    25
    26
    27

    Propensity‐score‐matched comparative analyses of simultaneously administered fixed‐ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2821, doi. 10.1111/dom.13462
    By:
    • Rosenstock, Julio;
    • Handelsman, Yehuda;
    • Vidal, Josep;
    • Ampudia Blasco, F. Javier;
    • Giorgino, Francesco;
    • Liu, Minzhi;
    • Perfetti, Riccardo;
    • Meier, Juris J.
    Publication type:
    Article
    28
    29
    30

    Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 10, p. 1490, doi. 10.1111/dom.12960
    By:
    • Metzger, Muriel;
    • Castañeda, Javier;
    • Reznik, Yves;
    • Giorgino, Francesco;
    • Conget, Ignacio;
    • Aronson, Ronnie;
    • de Portu, Simona;
    • Runzis, Sarah;
    • Lee, Scott W.;
    • Cohen, Ohad
    Publication type:
    Article
    31
    32
    33

    The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in type 2 diabetes patients (TROPHIES): resource use and costs of treatment in clinical practice in France, Germany, and Italy.

    Published in:
    Journal of Medical Economics, 2024, v. 27, n. 1, p. 866, doi. 10.1080/13696998.2024.2367919
    By:
    • Barrett, Annabel;
    • Boye, Kristina S.;
    • García-Pérez, Luis-Emilio;
    • Giorgino, Francesco;
    • Guerci, Bruno;
    • Füchtenbusch, Martin;
    • Yu, Maria;
    • Sapin, Hélène;
    • Dib, Anne;
    • Heitmann, Elke;
    • Federici, Marco Orsini;
    • Lebrec, Jérémie
    Publication type:
    Article
    34
    35

    Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes.

    Published in:
    Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01481-0
    By:
    • Schnell, Oliver;
    • Battelino, Tadej;
    • Bergenstal, Richard;
    • Blüher, Matthias;
    • Böhm, Michael;
    • Brosius, Frank;
    • Carr, Richard D.;
    • Ceriello, Antonio;
    • Forst, Thomas;
    • Giorgino, Francesco;
    • Guerci, Bruno;
    • Heerspink, Hiddo J. L.;
    • Itzhak, Baruch;
    • Ji, Linong;
    • Kosiborod, Mikhail;
    • Lalić, Nebojša;
    • Lehrke, Michael;
    • Marx, Nikolaus;
    • Nauck, Michael;
    • Rodbard, Helena W.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders.

    Published in:
    Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1175640
    By:
    • Sordi, Valeria;
    • Monti, Paolo;
    • Lampasona, Vito;
    • Melzi, Raffaella;
    • Pellegrini, Silvia;
    • Keymeulen, Bart;
    • Gillard, Pieter;
    • Linn, Thomas;
    • Bosi, Emanuele;
    • Rose, Ludger;
    • Pozzilli, Paolo;
    • Giorgino, Francesco;
    • Cossu, Efisio;
    • Piemonti, Lorenzo
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    Gut: A key player in the pathogenesis of type 2 diabetes?

    Published in:
    2018
    By:
    • Muscogiuri, Giovanna;
    • Balercia, Giancarlo;
    • Barrea, Luigi;
    • Cignarelli, Angelo;
    • Giorgino, Francesco;
    • Holst, Jens J.;
    • Laudisio, Daniela;
    • Orio, Francesco;
    • Tirabassi, Giacomo;
    • Colao, Annamaria
    Publication type:
    journal article
    49
    50